A new study by the CDC finds two doses of the Pfizer vaccine was 91 percent effective in preventing MIS-C in kids 12 to 18. ... St. Germain said even if your child's COVID-19 symptoms are mild, three to four weeks later, their body could respond to the infection with MIS-C.